Bone marrow transplantation may increase cancer resistance in patients

	Tweet

Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a study led by Dr. Vivek Rangnekar, associate director of translational research for the Markey Cancer Center at the University of Kentucky.

Bone marrow, a spongy tissue inside bones, contains stem cells that produce blood cells, including leukocytes, erythrocytes and platelets. In the cover story of the July issue of Cancer Biology & Therapy, Rangnekar and his team explore the transfer of bone marrow from Par-4/SAC-transgenic donor mice to control mice as a means of transferring anti-cancer potential.

Par-4 (also known as PAWR) is a tumor suppressor protein that selectively induces apoptosis in cancer cells, but not normal cells. This function of Par-4 is mediated by its central core domain, SAC. SAC-transgenic mice are resistant to the growth of spontaneous and inducible tumors.

After transplantation, the researchers discovered the expression of cancer-killer SAC-GFP activity in bone marrow cells of the recipient mice, implying the successful transfer and colonization of the anti-cancer tissue from the donors. In addition, soluble Par-4 or SAC protein injected into mice inhibited the growth of metastatic tumors.

Rangnekar, the Alfred Cohen Endowed Chair of Oncology Research at Markey, says the study shows promise for treating both primary and metastatic tumors.

“We are excited by the findings of this study as they indicate that secreted Par-4 is systemically active in mice,” Rangnekar said. “Optimization of the bone marrow transplantation procedure using stem cells that are genetically modified to systemically secrete potent protein payloads of Par-4/SAC killer activity may offer a new approach to treat not only primary tumors but also metastatic tumors of diverse origin.”

###

Contact: Allison Perry

859-323-2399
University of Kentucky

RELATED STORIES:
Life after chemotherapy: Daily tasks, quality of life may be affected, MU researcher finds   Teenagers and young adults more likely to survive cancer in Australia than in the USA   Cancer death rates continue drop: report   Nicotine promotes growth of established tumors   Cancer Gene Drives Pivotal Decision in Early Brain Development   Green tea may curb risk of some cancers   Take Action to Prevent Cancer: Participate in a Prevention Study   Diet, growth are major cancer causes: report   Antibody signal may redirect inflammation to fuel cancer   Study Shows Immune System Can Hurt As Well As Help Fight Cancer   Hereditary cancer risk   Drug combination boosts survival rate in head and neck cancers   Lung cancer tied to family risk of other cancers   Higher vitamin K intake tied to lower cancer risks   Mobile Phone Use Not Linked to Increased Risk of Glioma Brain Tumours   1 disease, not 1 demographic   Researchers Find Melanoma Not Caused by Early UVA Light Exposure   Fruit research yields way to curb cancer   Research Finds New Link Between Inflammation and Cancer   Stem-Cell Sentry Sounds the Alarm to Maintain Balance Between Cancer and Aging   Repeat imaging in kids with cancer: a balancing act   Gene Therapy Improves Survival and Quality of Life of Dogs with Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]